Invitation

[Guest guest]

Dear Groups,

One of the first purchasers of the 21CUPC manuscript recently had a 'grumble' that he did not feel the Copyright* entitled him to show his doctor a copy of the paper. All he needed to do was write to me months ago, as I am always asking for feedback, so, anyway ..

Although I do want a tight control over my authorship rights to the novel ideas expressed in the manuscript, I recognise that patients need to let their doctors know what the possibilities are in treating prostate cancer in a way that will avoid HRPC. Therefore, anyone who purchases a copy of the manuscript may give their doctor a hard copy under the caveat of "educational purposes". However, I should be grateful if patients would ask their doctors to obtain further copies from the website in the accustomed way that we do business in this part of the world (i.e. honest trading).

In addition, a new group is opening up to discuss matters raised in the 21CUPC manuscript. Description below. Anyone can join, but it is in your interest to have a copy of the paper so you know what the discussion is about .. ..

A 21st Century Understanding of Prostate Cancer: challenges the 60 year old notion that castration is the backbone of systemic treatment for prostate cancer. Many years ago, the castration option was being challenged by doctors. Here are two very old examples from a library archive not available on the internet: From: Cancer Research; 1956. pp 473-9 ; By: Olaf H. PEARSON Discussion of Dr. Huggins' Paper "Control of Cancers of Man by Endocrinological Methods" Case I: An untreated patient with advanced prostatic cancer with severe bone pain from osseous metastases was given testosterone propionate. There was prompt relief of pain, and within a few weeks he was asymptomatic. He was treated with testosterone propionate, 50 mg/day, for 9 months, during which time he was well. .. Case II: This patient with advanced prostatic cancer had responded well to castration for several years. When there was a relapse following castration, estrogen and cortisone therapy failed to induce improvement. ... Testosterone administration produced a striking fall in serum acid phosphatase, a rise in hemoglobin level, and symptomatic improvement." Sadly, positive androgen management, the other side of the coin to castration therapy is shouted down by those in the medical profession who have a vested interest in prescribing expensive designer drugs that replace the knife, but castrate all the same (i.e. drugs like Zoladex, Casodex, Avodart). Now the challenge to investigate other ways of managing this disease is offered to you. This is an educational site and no claim to diagnose or treat any disease is made. If you have prostate cancer you should be under the care a competant physician who understands your needs.Cheers,

Sammy.

http://www.prostateman.org/

*

No part of this document may be reproduced, stored in or introduced into a retrieval system, or transmitted, in any form or by any means (electronic, photocopying recording or otherwise),

without the prior written permission of the copyright owner. No special privilege, and no warranty as to completeness, accuracy, fitness for purpose, is implied to any individual or institution.